Biologics Contract Manufacturing Market, By Biologic, By Service Type, By Scale, By Therapeutic Area, By Production, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033

Description

Biologics Contract Manufacturing Market size was valued at US$ 35,118.82 Million in 2025, expanding at a CAGR of 10.20% from 2026 to 2033.

The outsourcing of production of biologics, complex medicines derived from living systems like cell therapies, gene-based products, recombinant proteins, or vaccines to specialized experts' organizations is known as CMOs, and this entire process is named as Biologics contract manufacturing. This model helps drug companies' lower risk with advanced technology and skilled expertise, and by delivering medicine faster to patients effectively and efficiently. The Biologics Contract Manufacturing Market is supported by the rising volume of biologic therapy approvals and advancement of stricter manufacturing and quality oversight standards. The U.S. FDA continues to expand biologics guidance, facility inspections, and accelerated approval pathways, which encourage more outsourcing partnerships worldwide. In addition, the FDA reported around 44 new drug approvals in 2024, many of which included biologics and advanced therapies, increasing demand for external manufacturing support.

Biologics Contract Manufacturing Market- Market Dynamics

Rising Global Demand for Biologic Therapies

The fast-tracking expansion shift toward biologic therapies retains one of the most powerful long-term growth drivers for this market. Compared with conservative small-molecule medicines, biologics are extensive therapies from living systems and are gaining significant traction in oncology treatment, autoimmune disorders, rare diseases, and infectious conditions because of their targeted clinical benefits. Regulatory approval trends also strengthen this momentum, with biologics constantly representing one-third of recent FDA drug approvals and reaching about 40% in certain years, highlighting their expanding role in modern therapeutics. This increasing development pipeline is placing significant pressure on manufacturing capacity, especially among biotech innovators that often lack the capital and technical resources to build dedicated biologics plants. As a result, contract manufacturing companies become trusted partners for biotech and pharmaceutical entities by ensuring technical support and skills with strong guidance. Their support and approach reduce burden and bring new biologic medicines to market faster, and provide a dependable product supply.

Biologics Contract Manufacturing Market- Segmentation Analysis:

The Global Biologics Contract Manufacturing Market is segmented on the basis of Biologic, Service Type, Scale, Therapeutic Area, Production, and Region.

According to biologic segments, Monoclonal antibodies (mAbs) are extremely targeted biologic medicines planned to identify and attack specific disease cells, which enable them to be widely used in cancer, autoimmune diseases, infections, and rare disorders. This proven treatment approach and utilization of medicine sustain growth and demand. Top CDMOs are steadily expanding facilities dedicated to antibody production. For instance, Lonza continues to generate a significant share of its biologics revenue from monoclonal antibodies and related bioconjugates, showing the commercial strength of this area. Likewise, WuXi Biologics has substantially increased its mammalian cell culture capacity to support large-scale antibody manufacturing for global clients. In layman's words, because these medicines are trusted, widely needed, and easier to scale through established production systems, mAbs remain the most reliable long-term outsourcing opportunity in biologics manufacturing.

Among Preclinical Scale, Commercial, and Flexible or Multi-Scale Facilities, Commercial segment plays a vital role in this market. The primary factor is that drugs receive approval from statutory bodies, and require large, batch production, validated quality systems, and long-term supply reliability, which logically increases dependency on commercial-scale CDMO partners. This stage generates sustained manufacturing volumes for monoclonal antibodies, vaccines, recombinant proteins, and biosimilars over multiple years. Establishment developments strongly support this direction. Samsung Biologics reported full utilization across Plants 1-4 in 2025, helping the company achieve KRW 4,557 billion in annual CDMO revenue, clearly reflecting the importance of commercial manufacturing demand. Similarly, Lonza highlighted that large pharmaceutical organizations contribute the majority of CDMO revenues primarily through commercial manufacturing activity, supported by continued high utilization of its commercial biologics assets.

Biologics Contract Manufacturing Market- Geographical Insights

As healthcare systems continue prioritizing biologics, regional capabilities in compliance, capacity, and technology access are becoming central to future industry movement. In North America is expected to remain influential in the biologics contract manufacturing market, as the U.S FDA reported 44 new drug approvals in 2024, including several biologics and advanced therapies that require specialized outsourced manufacturing support, reinforcing sustained demand for certified CDMO infrastructure. Simultaneously U.S. policy emphasis on domestic pharmaceutical production has encouraged reshoring, with Thermo Fisher confirming multiple new biologics and pharma service contracts in 2026 tied to production shifts into the U.S. A notable example is Thermo Fisher Scientific, which has recently secured multiple contracts linked to U.S. reshoring efforts as drug companies shift manufacturing from Europe and Asia back to America, reflecting strong policy momentum toward domestic supply chain resilience. This blend of strong regulatory systems, support for public funding, and advancement of manufacturing facilities sustains to reinforce North America's leadership in biologics market. On the other side, the Asia Pacific region is increasingly recognized as a dynamic growth hub for biopharmaceutical development and manufacturing. Countries such as China, India, and South Korea are rapidly scaling their biopharma industries, contributing substantially to the global biologics pipeline and manufacturing services.

Indonesia Biologics Contract Manufacturing Market- Country Insights

Indonesia is steadily emerging as a meaningful player in the biologics contract manufacturing landscape by strengthening domestic biopharmaceutical capabilities and encouraging technology transfer aligned with national healthcare self-reliance goals. Government support through BPOM certification and policy backing has helped local companies build globally compliant facilities. A strong example is PT Etana Biotechnologies, whose BPOM-certified biopharmaceutical plant was inaugurated with presidential support to expand local vaccine and biologics production. In parallel, Kalbio Global Medika continues to enhance Indonesia's contract manufacturing ecosystem through cGMP biologics development, monoclonal antibody production, biosimilar manufacturing, and fill-finish services for both local and international markets. These advancements highlight Indonesia's broader strategy to improve health security, reduce reliance on imported biologics, and create a more resilient regional supply base. As infrastructure, regulatory maturity, and industry partnerships continue to strengthen, the country is gradually building a sustainable biologics manufacturing environment capable of supporting long-term domestic and Southeast Asian demand.

Biologics Contract Manufacturing Market- Competitive Landscape:

The rising complexity of biologic medicines is steadily increasing dependence on specialized contract development and manufacturing organizations (CDMOs), as many pharmaceutical and biotech companies prefer outsourcing over building expensive in-house facilities. This has led well known service providers such as Lonza, Samsung Biologics, WuXi Biologics, Thermo Fisher Scientific, and Catalent to strengthen their service offerings across end to end biologic development and manufacturing. These organisations supply biologics from early stage clinical batches to commercial scale production, and they reach clients through direct corporate platforms, industry partnerships, and strategic collaborations. A notable example is Samsung Biologics ' acquisition of a U.S. production facility from GSK for USD 280 million underscores how major providers are expanding presence and production capacity to meet long term demand. Trusted manufacturers like Boehringer Ingelheim BioXcellence, Fujifilm Diosynth Biotechnologies, AGC Biologics, and Vetter Pharma are deploying funds in new technologies, Companies are also extending collaborations and building long term manufacturing agreements that help secure steady workflows with their clients while reducing operational risk. These developments reflect a general industry shift in which outsourcing partners are seen as extensions of internal manufacturing teams, enabling sponsors to focus more on innovation and less on capital intensive infrastructure ownership.

Recent Developments:

In July 2025, Lonza reported a strong business turnaround, with its core biologics CDMO unit growing revenue significantly in the first half of the year under a renewed strategy that emphasised investment in biologics production capabilities. This development highlights Samsung Biologics' growing strategic presence in Japan and reinforces its role as a trusted global biologics manufacturing partner.

In October 2025, Samsung Biologics secured multiple contracts with top Japanese pharmaceutical firms, completing deals with four of Japan's leading companies while negotiating further partnerships to extend its manufacturing reach. This move strengthens Thermo Fisher's U.S. sterile manufacturing network, expands fill-finish capacity, and reinforces long-term strategic supply commitments with Sanofi.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

AbbVie, Inc.
Abzena Ltd.
Acino International AG
ADMA Biologics, Inc.
AGC Biologics
Ajinomoto Bio-Pharma Services
Avid Bioservices, Inc.
Baxter International, Inc
Boehringer Ingelheim Biopharmaceuticals GmbH by ArisGlobal Company
Cambrex Corporation
Catalent, Inc.
Emergent BioSolutions, Inc.
FUJIFILM Diosynth Biotechnologies U.S.A., Inc. by FUJIFILM Corporation
JSR Life Sciences, LLC by JSR Group
Kemwell Biopharma Pvt. Ltd.
Lonza Group Ltd.
Midas Pharma GmbH
ProBioGen AG
Recipharm AB
Rentschler Biopharma SE
Samsung Biologics
Thermo Fisher Scientific, Inc.
Toyobo Co. Ltd.
Wacker Chemie AG
WuXi Biologics Co., Ltd.
Others

GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET, BY BIOLOGIC- MARKET ANALYSIS, 2020 - 2033

Antibody-Drug Conjugates
Cell And Gene Therapies
Vaccines
Recombinant Proteins & Enzymes
Monoclonal Antibodies
Others

GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE- MARKET ANALYSIS, 2020 - 2033

Analytical And Quality Control
Fill-Finish & Packaging Services
Packaging
Labeling And Ancillary Services
Durg Substance
Process Development & Tech Transfer

GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET, BY SCALE- MARKET ANALYSIS, 2020 - 2033

Preclinical Scale
Commercial
Flexible or Multi-Scale Facilities

GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET, BY THERAPEUTIC AREA- MARKET ANALYSIS, 2020 - 2033

Oncology
Immunology And Autoimmune Disorders
Infectious Diseases & Vaccinology
Cardiovascular And Renal Disorder
Neurology And Central Nervous System
Metabolic And Endocrine Disorders
Respiratory Disorders
Others

GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET, BY PRODUCTION- MARKET ANALYSIS, 2020 - 2033

Mammalian Systems
Microbial System
Alternative System
Others

GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Denmark
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Taiwan
Vietnam
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Iran
Qatar
Rest of MEA

Product Code: ANV6382

1. Biologics Contract Manufacturing Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Biologics Contract Manufacturing Market Snippet by Biologic
- 2.1.2. Biologics Contract Manufacturing Market Snippet by Service Type
- 2.1.3. Biologics Contract Manufacturing Market Snippet by Scale
- 2.1.4. Biologics Contract Manufacturing Market Snippet by Therapeutic Area
- 2.1.5. Biologics Contract Manufacturing Market Snippet by Production
- 2.1.6. Biologics Contract Manufacturing Market Snippet by Country
- 2.1.7. Biologics Contract Manufacturing Market Snippet by Region
2.2. Competitive Insights

3. Biologics Contract Manufacturing Key Market Trends

3.1. Biologics Contract Manufacturing Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Biologics Contract Manufacturing Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Biologics Contract Manufacturing Market Opportunities
3.4. Biologics Contract Manufacturing Market Future Trends

4. Biologics Contract Manufacturing Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Biologics Contract Manufacturing Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Biologics Contract Manufacturing Market Landscape

6.1. Biologics Contract Manufacturing Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Biologics Contract Manufacturing Market - By Biologic

7.1. Overview
- 7.1.1. Segment Share Analysis, By Biologic, 2025 & 2033 (%)
- 7.1.2. Antibody-Drug Conjugates
- 7.1.3. Cell And Gene Therapies
- 7.1.4. Vaccines
- 7.1.5. Recombinant Proteins & Enzymes
- 7.1.6. Monoclonal Antibodies
- 7.1.7. Others

8. Biologics Contract Manufacturing Market - By Service Type

8.1. Overview
- 8.1.1. Segment Share Analysis, By Service Type, 2025 & 2033 (%)
- 8.1.2. Analytical And Quality Control
- 8.1.3. Fill-Finish & Packaging Services
- 8.1.4. Packaging
- 8.1.5. Labeling And Ancillary Services
- 8.1.6. Durg Substance
- 8.1.7. Process Development & Tech Transfer

9. Biologics Contract Manufacturing Market - By Scale

9.1. Overview
- 9.1.1. Segment Share Analysis, By Scale, 2025 & 2033 (%)
- 9.1.2. Preclinical Scale
- 9.1.3. Commercial
- 9.1.4. Flexible Or Multi-Scale Facilities

10. Biologics Contract Manufacturing Market - By Therapeutic Area

10.1. Overview
- 10.1.1. Segment Share Analysis, By Therapeutic Area, 2025 & 2033 (%)
- 10.1.2. Oncology
- 10.1.3. Immunology And Autoimmune Disorders
- 10.1.4. Infectious Diseases & Vaccinology
- 10.1.5. Cardiovascular And Renal Disorder
- 10.1.6. Neurology And Central Nervous System
- 10.1.7. Metabolic And Endocrine Disorders
- 10.1.8. Respiratory Disorders
- 10.1.9. Others

11. Biologics Contract Manufacturing Market - By Production

11.1. Overview
- 11.1.1. Segment Share Analysis, By Production, 2025 & 2033 (%)
- 11.1.2. Mammalian Systems
- 11.1.3. Microbial System
- 11.1.4. Alternative System
- 11.1.5. Others

12. Biologics Contract Manufacturing Market- By Geography

12.1. Introduction
- 12.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
12.2. North America
- 12.2.1. Overview
- 12.2.2. Biologics Contract Manufacturing Key Manufacturers in North America
- 12.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.2.4. North America Market Size and Forecast, By Biologic, 2020 - 2033 (US$ Million)
- 12.2.5. North America Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
- 12.2.6. North America Market Size and Forecast, By Scale, 2020 - 2033 (US$ Million)
- 12.2.7. North America Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
- 12.2.8. North America Market Size and Forecast, By Production, 2020 - 2033 (US$ Million)
- 12.2.9. U.S.
  - 12.2.9.1. Overview
  - 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.2.9.3. U.S. Market Size and Forecast, By Biologic, 2020 - 2033 (US$ Million)
  - 12.2.9.4. U.S. Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.2.9.5. U.S. Market Size and Forecast, By Scale, 2020 - 2033 (US$ Million)
  - 12.2.9.6. U.S. Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.2.9.7. U.S. Market Size and Forecast, By Production, 2020 - 2033 (US$ Million)
- 12.2.10. Canada
  - 12.2.10.1. Overview
  - 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.2.10.3. Canada Market Size and Forecast, By Biologic, 2020 - 2033 (US$ Million)
  - 12.2.10.4. Canada Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.2.10.5. Canada Market Size and Forecast, By Scale, 2020 - 2033 (US$ Million)
  - 12.2.10.6. Canada Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.2.10.7. Canada Market Size and Forecast, By Production, 2020 - 2033 (US$ Million)
12.3. Europe
- 12.3.1. Overview
- 12.3.2. Biologics Contract Manufacturing Key Manufacturers in Europe
- 12.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.3.4. Europe Market Size and Forecast, By Biologic, 2020 - 2033 (US$ Million)
- 12.3.5. Europe Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
- 12.3.6. Europe Market Size and Forecast, By Scale, 2020 - 2033 (US$ Million)
- 12.3.7. Europe Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
- 12.3.8. Europe Market Size and Forecast, By Production, 2020 - 2033 (US$ Million)
- 12.3.9. Germany
  - 12.3.9.1. Overview
  - 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.9.3. Germany Market Size and Forecast, By Biologic, 2020 - 2033 (US$ Million)
  - 12.3.9.4. Germany Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.3.9.5. Germany Market Size and Forecast, By Scale, 2020 - 2033 (US$ Million)
  - 12.3.9.6. Germany Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.3.9.7. Germany Market Size and Forecast, By Production, 2020 - 2033 (US$ Million)
- 12.3.10. UK
  - 12.3.10.1. Overview
  - 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.10.3. UK Market Size and Forecast, By Biologic, 2020 - 2033 (US$ Million)
  - 12.3.10.4. UK Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.3.10.5. UK Market Size and Forecast, By Scale, 2020 - 2033 (US$ Million)
  - 12.3.10.6. UK Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.3.10.7. UK Market Size and Forecast, By Production, 2020 - 2033 (US$ Million)
- 12.3.11. France
  - 12.3.11.1. Overview
  - 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.11.3. France Market Size and Forecast, By Biologic, 2020 - 2033 (US$ Million)
  - 12.3.11.4. France Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.3.11.5. France Market Size and Forecast, By Scale, 2020 - 2033 (US$ Million)
  - 12.3.11.6. France Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.3.11.7. France Market Size and Forecast, By Production, 2020 - 2033 (US$ Million)
- 12.3.12. Italy
  - 12.3.12.1. Overview
  - 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.12.3. Italy Market Size and Forecast, By Biologic, 2020 - 2033 (US$ Million)
  - 12.3.12.4. Italy Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.3.12.5. Italy Market Size and Forecast, By Scale, 2020 - 2033 (US$ Million)
  - 12.3.12.6. Italy Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.3.12.7. Italy Market Size and Forecast, By Production, 2020 - 2033 (US$ Million)
- 12.3.13. Spain
  - 12.3.13.1. Overview
  - 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.13.3. Spain Market Size and Forecast, By Biologic, 2020 - 2033 (US$ Million)
  - 12.3.13.4. Spain Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.3.13.5. Spain Market Size and Forecast, By Scale, 2020 - 2033 (US$ Million)
  - 12.3.13.6. Spain Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.3.13.7. Spain Market Size and Forecast, By Production, 2020 - 2033 (US$ Million)
- 12.3.14. The Netherlands
  - 12.3.14.1. Overview
  - 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.14.3. The Netherlands Market Size and Forecast, By Biologic, 2020 - 2033 (US$ Million)
  - 12.3.14.4. The Netherlands Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.3.14.5. The Netherlands Market Size and Forecast, By Scale, 2020 - 2033 (US$ Million)
  - 12.3.14.6. The Netherlands Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.3.14.7. The Netherlands Market Size and Forecast, By Production, 2020 - 2033 (US$ Million)
- 12.3.15. Sweden
  - 12.3.15.1. Overview
  - 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.15.3. Sweden Market Size and Forecast, By Biologic, 2020 - 2033 (US$ Million)
  - 12.3.15.4. Sweden Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.3.15.5. Sweden Market Size and Forecast, By Scale, 2020 - 2033 (US$ Million)
  - 12.3.15.6. Sweden Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.3.15.7. Sweden Market Size and Forecast, By Production, 2020 - 2033 (US$ Million)
- 12.3.16. Russia
  - 12.3.16.1. Overview
  - 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.16.3. Russia Market Size and Forecast, By Biologic, 2020 - 2033 (US$ Million)
  - 12.3.16.4. Russia Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.3.16.5. Russia Market Size and Forecast, By Scale, 2020 - 2033 (US$ Million)
  - 12.3.16.6. Russia Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.3.16.7. Russia Market Size and Forecast, By Production, 2020 - 2033 (US$ Million)
- 12.3.17. Poland
  - 12.3.17.1. Overview
  - 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.17.3. Poland Market Size and Forecast, By Biologic, 2020 - 2033 (US$ Million)
  - 12.3.17.4. Poland Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.3.17.5. Poland Market Size and Forecast, By Scale, 2020 - 2033 (US$ Million)
  - 12.3.17.6. Poland Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.3.17.7. Poland Market Size and Forecast, By Production, 2020 - 2033 (US$ Million)
- 12.3.18. Denmark
  - 12.3.18.1. Overview
  - 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.18.3. Denmark Market Size and Forecast, By Biologic, 2020 - 2033 (US$ Million)
  - 12.3.18.4. Denmark Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.3.18.5. Denmark Market Size and Forecast, By Scale, 2020 - 2033 (US$ Million)
  - 12.3.18.6. Denmark Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.3.18.7. Denmark Market Size and Forecast, By Production, 2020 - 2033 (US$ Million)
- 12.3.19. Rest of Europe
  - 12.3.19.1. Overview
  - 12.3.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.3.19.3. Rest of the Europe Market Size and Forecast, By Biologic, 2020 - 2033 (US$ Million)
  - 12.3.19.4. Rest of the Europe Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.3.19.5. Rest of the Europe Market Size and Forecast, By Scale, 2020 - 2033 (US$ Million)
  - 12.3.19.6. Rest of the Europe Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.3.19.7. Rest of the Europe Market Size and Forecast, By Production, 2020 - 2033 (US$ Million)
12.4. Asia Pacific (APAC)
- 12.4.1. Overview
- 12.4.2. Biologics Contract Manufacturing Key Manufacturers in Asia Pacific
- 12.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.4.4. APAC Market Size and Forecast, By Biologic, 2020 - 2033 (US$ Million)
- 12.4.5. APAC Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
- 12.4.6. APAC Market Size and Forecast, By Scale, 2020 - 2033 (US$ Million)
- 12.4.7. APAC Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
- 12.4.8. APAC Market Size and Forecast, By Production, 2020 - 2033 (US$ Million)
- 12.4.9. China
  - 12.4.9.1. Overview
  - 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.9.3. China Market Size and Forecast, By Biologic, 2020 - 2033 (US$ Million)
  - 12.4.9.4. China Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.4.9.5. China Market Size and Forecast, By Scale, 2020 - 2033 (US$ Million)
  - 12.4.9.6. China Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.4.9.7. China Market Size and Forecast, By Production, 2020 - 2033 (US$ Million)
- 12.4.10. India
  - 12.4.10.1. Overview
  - 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.10.3. India Market Size and Forecast, By Biologic, 2020 - 2033 (US$ Million)
  - 12.4.10.4. India Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.4.10.5. India Market Size and Forecast, By Scale, 2020 - 2033 (US$ Million)
  - 12.4.10.6. India Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.4.10.7. India Market Size and Forecast, By Production, 2020 - 2033 (US$ Million)
- 12.4.11. Japan
  - 12.4.11.1. Overview
  - 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.11.3. Japan Market Size and Forecast, By Biologic, 2020 - 2033 (US$ Million)
  - 12.4.11.4. Japan Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.4.11.5. Japan Market Size and Forecast, By Scale, 2020 - 2033 (US$ Million)
  - 12.4.11.6. Japan Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.4.11.7. Japan Market Size and Forecast, By Production, 2020 - 2033 (US$ Million)
- 12.4.12. South Korea
  - 12.4.12.1. Overview
  - 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.12.3. South Korea Market Size and Forecast, By Biologic, 2020 - 2033 (US$ Million)
  - 12.4.12.4. South Korea Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.4.12.5. South Korea Market Size and Forecast, By Scale, 2020 - 2033 (US$ Million)
  - 12.4.12.6. South Korea Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.4.12.7. South Korea Market Size and Forecast, By Production, 2020 - 2033 (US$ Million)
- 12.4.13. Australia
  - 12.4.13.1. Overview
  - 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.13.3. Australia Market Size and Forecast, By Biologic, 2020 - 2033 (US$ Million)
  - 12.4.13.4. Australia Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.4.13.5. Australia Market Size and Forecast, By Scale, 2020 - 2033 (US$ Million)
  - 12.4.13.6. Australia Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.4.13.7. Australia Market Size and Forecast, By Production, 2020 - 2033 (US$ Million)
- 12.4.14. Indonesia
  - 12.4.14.1. Overview
  - 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.14.3. Indonesia Market Size and Forecast, By Biologic, 2020 - 2033 (US$ Million)
  - 12.4.14.4. Indonesia Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.4.14.5. Indonesia Market Size and Forecast, By Scale, 2020 - 2033 (US$ Million)
  - 12.4.14.6. Indonesia Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.4.14.7. Indonesia Market Size and Forecast, By Production, 2020 - 2033 (US$ Million)
- 12.4.15. Thailand
  - 12.4.15.1. Overview
  - 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.15.3. Thailand Market Size and Forecast, By Biologic, 2020 - 2033 (US$ Million)
  - 12.4.15.4. Thailand Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.4.15.5. Thailand Market Size and Forecast, By Scale, 2020 - 2033 (US$ Million)
  - 12.4.15.6. Thailand Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.4.15.7. Thailand Market Size and Forecast, By Production, 2020 - 2033 (US$ Million)
- 12.4.16. Philippines
  - 12.4.16.1. Overview
  - 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.16.3. Philippines Market Size and Forecast, By Biologic, 2020 - 2033 (US$ Million)
  - 12.4.16.4. Philippines Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.4.16.5. Philippines Market Size and Forecast, By Scale, 2020 - 2033 (US$ Million)
  - 12.4.16.6. Philippines Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.4.16.7. Philippines Market Size and Forecast, By Production, 2020 - 2033 (US$ Million)
- 12.4.17. Taiwan
  - 12.4.17.1. Overview
  - 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.17.3. Taiwan Market Size and Forecast, By Biologic, 2020 - 2033 (US$ Million)
  - 12.4.17.4. Taiwan Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.4.17.5. Taiwan Market Size and Forecast, By Scale, 2020 - 2033 (US$ Million)
  - 12.4.17.6. Taiwan Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.4.17.7. Taiwan Market Size and Forecast, By Production, 2020 - 2033 (US$ Million)
- 12.4.18. Vietnam
  - 12.4.18.1. Overview
  - 12.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.18.3. Vietnam Market Size and Forecast, By Biologic, 2020 - 2033 (US$ Million)
  - 12.4.18.4. Vietnam Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.4.18.5. Vietnam Market Size and Forecast, By Scale, 2020 - 2033 (US$ Million)
  - 12.4.18.6. Vietnam Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.4.18.7. Vietnam Market Size and Forecast, By Production, 2020 - 2033 (US$ Million)
- 12.4.19. Rest of APAC
  - 12.4.19.1. Overview
  - 12.4.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.4.19.3. Rest of APAC Market Size and Forecast, By Biologic, 2020 - 2033 (US$ Million)
  - 12.4.19.4. Rest of APAC Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.4.19.5. Rest of APAC Market Size and Forecast, By Scale, 2020 - 2033 (US$ Million)
  - 12.4.19.6. Rest of APAC Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.4.19.7. Rest of APAC Market Size and Forecast, By Production, 2020 - 2033 (US$ Million)
12.5. Latin America (LATAM)
- 12.5.1. Overview
- 12.5.2. Biologics Contract Manufacturing Key Manufacturers in Latin America
- 12.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.5.4. LATAM Market Size and Forecast, By Biologic, 2020 - 2033 (US$ Million)
- 12.5.5. LATAM Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
- 12.5.6. LATAM Market Size and Forecast, By Scale, 2020 - 2033 (US$ Million)
- 12.5.7. LATAM Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
- 12.5.8. LATAM Size and Forecast, By Production, 2020 - 2033 (US$ Million)
- 12.5.9. Brazil
  - 12.5.9.1. Overview
  - 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.9.3. Brazil Market Size and Forecast, By Biologic, 2020 - 2033 (US$ Million)
  - 12.5.9.4. Brazil Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.5.9.5. Brazil Market Size and Forecast, By Scale, 2020 - 2033 (US$ Million)
  - 12.5.9.6. Brazil Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.5.9.7. Brazil Market Size and Forecast, By Production, 2020 - 2033 (US$ Million)
- 12.5.10. Mexico
  - 12.5.10.1. Overview
  - 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.10.3. Mexico Market Size and Forecast, By Biologic, 2020 - 2033 (US$ Million)
  - 12.5.10.4. Mexico Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.5.10.5. Mexico Market Size and Forecast, By Scale, 2020 - 2033 (US$ Million)
  - 12.5.10.6. Mexico Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.5.10.7. Mexico Market Size and Forecast, By Production, 2020 - 2033 (US$ Million)
- 12.5.11. Argentina
  - 12.5.11.1. Overview
  - 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.11.3. Argentina Market Size and Forecast, By Biologic, 2020 - 2033 (US$ Million)
  - 12.5.11.4. Argentina Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.5.11.5. Argentina Market Size and Forecast, By Scale, 2020 - 2033 (US$ Million)
  - 12.5.11.6. Argentina Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.5.11.7. Argentina Market Size and Forecast, By Production, 2020 - 2033 (US$ Million)
- 12.5.12. Colombia
  - 12.5.12.1. Overview
  - 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.12.3. Colombia Market Size and Forecast, By Biologic, 2020 - 2033 (US$ Million)
  - 12.5.12.4. Colombia Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.5.12.5. Colombia Market Size and Forecast, By Scale, 2020 - 2033 (US$ Million)
  - 12.5.12.6. Colombia Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.5.12.7. Colombia Market Size and Forecast, By Production, 2020 - 2033 (US$ Million)
- 12.5.13. Rest of LATAM
  - 12.5.13.1. Overview
  - 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.5.13.3. Rest of LATAM Market Size and Forecast, By Biologic, 2020 - 2033 (US$ Million)
  - 12.5.13.4. Rest of LATAM Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.5.13.5. Rest of LATAM Market Size and Forecast, By Scale, 2020 - 2033 (US$ Million)
  - 12.5.13.6. Rest of LATAM Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.5.13.7. Rest of LATAM Market Size and Forecast, By Production, 2020 - 2033 (US$ Million)
12.6. Middle East and Africa
- 12.6.1. Overview
- 12.6.2. Biologics Contract Manufacturing Key Manufacturers in Middle East and Africa
- 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 12.6.4. Middle East and Africa Market Size and Forecast, By Biologic, 2020 - 2033 (US$ Million)
- 12.6.5. Middle East and Africa Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
- 12.6.6. Middle East and Africa Market Size and Forecast, By Scale, 2020 - 2033 (US$ Million)
- 12.6.7. Middle East and Africa Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
- 12.6.8. Middle East and Africa Market Size and Forecast, By Production, 2020 - 2033 (US$ Million)
- 12.6.9. Saudi Arabia
  - 12.6.9.1. Overview
  - 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.9.3. Saudi Arabia Market Size and Forecast, By Biologic, 2020 - 2033 (US$ Million)
  - 12.6.9.4. Saudi Arabia Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.6.9.5. Saudi Arabia Market Size and Forecast, By Scale, 2020 - 2033 (US$ Million)
  - 12.6.9.6. Saudi Arabia Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.6.9.7. Saudi Arabia Market Size and Forecast, By Production, 2020 - 2033 (US$ Million)
- 12.6.10. United Arab Emirates
  - 12.6.10.1. Overview
  - 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.10.3. United Arab Emirates Market Size and Forecast, By Biologic, 2020 - 2033 (US$ Million)
  - 12.6.10.4. United Arab Emirates Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.6.10.5. United Arab Emirates Market Size and Forecast, By Scale, 2020 - 2033 (US$ Million)
  - 12.6.10.6. United Arab Emirates Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.6.10.7. United Arab Emirates Market Size and Forecast, By Production, 2020 - 2033 (US$ Million)
- 12.6.11. Israel
  - 12.6.11.1. Overview
  - 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.11.3. Israel Market Size and Forecast, By Biologic, 2020 - 2033 (US$ Million)
  - 12.6.11.4. Israel Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.6.11.5. Israel Market Size and Forecast, By Scale, 2020 - 2033 (US$ Million)
  - 12.6.11.6. Israel Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.6.11.7. Israel Market Size and Forecast, By Production, 2020 - 2033 (US$ Million)
- 12.6.12. Turkey
  - 12.6.12.1. Overview
  - 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.12.3. Turkey Market Size and Forecast, By Biologic, 2020 - 2033 (US$ Million)
  - 12.6.12.4. Turkey Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.6.12.5. Turkey Market Size and Forecast, By Scale, 2020 - 2033 (US$ Million)
  - 12.6.12.6. Turkey Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.6.12.7. Turkey Market Size and Forecast, By Production, 2020 - 2033 (US$ Million)
- 12.6.13. Algeria
  - 12.6.13.1. Overview
  - 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.13.3. Algeria Market Size and Forecast, By Biologic, 2020 - 2033 (US$ Million)
  - 12.6.13.4. Algeria Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.6.13.5. Algeria Market Size and Forecast, By Scale, 2020 - 2033 (US$ Million)
  - 12.6.13.6. Algeria Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.6.13.7. Algeria Market Size and Forecast, By Production, 2020 - 2033 (US$ Million)
- 12.6.14. Egypt
  - 12.6.14.1. Overview
  - 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.14.3. Egypt Market Size and Forecast, By Biologic, 2020 - 2033 (US$ Million)
  - 12.6.14.4. Egypt Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.6.14.5. Egypt Market Size and Forecast, By Scale, 2020 - 2033 (US$ Million)
  - 12.6.14.6. Egypt Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.6.14.7. Egypt Market Size and Forecast, By Production, 2020 - 2033 (US$ Million)
- 12.6.15. Iran
  - 12.6.15.1. Overview
  - 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.15.3. Iran Market Size and Forecast, By Biologic, 2020 - 2033 (US$ Million)
  - 12.6.15.4. Iran Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.6.15.5. Iran Market Size and Forecast, By Scale, 2020 - 2033 (US$ Million)
  - 12.6.15.6. Iran Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.6.15.7. Iran Market Size and Forecast, By Production, 2020 - 2033 (US$ Million)
- 12.6.16. Qatar
  - 12.6.16.1. Overview
  - 12.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.16.3. Qatar Market Size and Forecast, By Biologic, 2020 - 2033 (US$ Million)
  - 12.6.16.4. Qatar Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.6.16.5. Qatar Market Size and Forecast, By Scale, 2020 - 2033 (US$ Million)
  - 12.6.16.6. Qatar Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.6.16.7. Qatar Market Size and Forecast, By Production, 2020 - 2033 (US$ Million)
- 12.6.17. Rest of MEA
  - 12.6.17.1. Overview
  - 12.6.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 12.6.17.3. Rest of MEA Market Size and Forecast, By Biologic, 2020 - 2033 (US$ Million)
  - 12.6.17.4. Rest of MEA Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
  - 12.6.17.5. Rest of MEA Market Size and Forecast, By Scale, 2020 - 2033 (US$ Million)
  - 12.6.17.6. Rest of MEA Market Size and Forecast, By Therapeutic Area, 2020 - 2033 (US$ Million)
  - 12.6.17.7. Rest of MEA Market Size and Forecast, By Production, 2020 - 2033 (US$ Million)

13. Key Vendor Analysis- Biologics Contract Manufacturing Industry

13.1. Competitive Benchmarking
- 13.1.1. Competitive Dashboard
- 13.1.2. Competitive Positioning
13.2. Company Profiles
- 13.2.1. AbbVie, Inc.
- 13.2.2. Abzena Ltd.
- 13.2.3. Acino International AG
- 13.2.4. ADMA Biologics, Inc.
- 13.2.5. AGC Biologics
- 13.2.6. Ajinomoto Bio-Pharma Services
- 13.2.7. Avid Bioservices, Inc.
- 13.2.8. Baxter International, Inc
- 13.2.9. Boehringer Ingelheim Biopharmaceuticals GmbH by ArisGlobal Company
- 13.2.10. Cambrex Corporation
- 13.2.11. Catalent, Inc.
- 13.2.12. Emergent BioSolutions, Inc.
- 13.2.13. FUJIFILM Diosynth Biotechnologies U.S.A., Inc. by FUJIFILM Corporation
- 13.2.14. JSR Life Sciences, LLC by JSR Group
- 13.2.15. Kemwell Biopharma Pvt. Ltd.
- 13.2.16. Lonza Group Ltd.
- 13.2.17. Midas Pharma GmbH
- 13.2.18. ProBioGen AG
- 13.2.19. Recipharm AB
- 13.2.20. Rentschler Biopharma SE
- 13.2.21. Samsung Biologics
- 13.2.22. Thermo Fisher Scientific, Inc.
- 13.2.23. Toyobo Co. Ltd.
- 13.2.24. Wacker Chemie AG
- 13.2.25. WuXi Biologics Co., Ltd.
- 13.2.26. Others

14. 360 Degree Analyst View

15. Appendix

15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us